Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying
Portfolio Pulse from Avi Kapoor
The article highlights recent insider transactions in three penny stocks: ONE Group Hospitality, Solo Brands, and Xeris Biopharma. Insider buying can indicate confidence in the company's prospects. ONE Group Hospitality posted strong quarterly earnings, Solo Brands reported disappointing Q2 results and lowered FY24 guidance, and Xeris Biopharma reported better-than-expected Q2 results and raised FY24 guidance.
August 13, 2024 | 12:53 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Solo Brands President and CEO Christopher T Metz acquired 250,000 shares at $1.30 each. The company reported disappointing Q2 results and lowered FY24 revenue guidance.
Despite insider buying, the disappointing Q2 results and lowered FY24 guidance may neutralize any positive impact on the stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
ONE Group Hospitality Director Jonathan Segal bought 5,000 shares at $3.53 each. The company recently posted strong quarterly earnings.
Insider buying coupled with strong quarterly earnings suggests positive sentiment and potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Xeris Biopharma Director John P. Schmid acquired 4,285 shares at $2.37 each. The company reported better-than-expected Q2 results and raised FY24 revenue guidance.
Insider buying along with better-than-expected Q2 results and raised FY24 guidance suggests a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80